Deepa Mulani [clinicaltrials_resource:1c17ed1a0bdd4dc16c33657dffd2c5aa]
ReSure Sealant Device Exposure Registry [clinicaltrials:NCT02309736]Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT02312544]Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis [clinicaltrials:NCT02445326]
overall contact [clinicaltrials_vocabulary:overall-contact]
Deepa Mulani [clinicaltrials_resource:1c17ed1a0bdd4dc16c33657dffd2c5aa]
Bio2RDF identifier
1c17ed1a0bdd4dc16c33657dffd2c5aa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1c17ed1a0bdd4dc16c33657dffd2c5aa
email [clinicaltrials_vocabulary:email]
dmulani@ocutx.com
last name [clinicaltrials_vocabulary:last-name]
Deepa Mulani
phone [clinicaltrials_vocabulary:phone]
781-357-4023
identifier
clinicaltrials_resource:1c17ed1a0bdd4dc16c33657dffd2c5aa
title
Deepa Mulani
@en
type
label
Deepa Mulani [clinicaltrials_resource:1c17ed1a0bdd4dc16c33657dffd2c5aa]
@en